Company Filing History:
3 out of 247 
2 out of 343 
1 out of 850 
Years Active: 1999-2016
Title: The Innovative Contributions of Sergio De Munari
Introduction
Sergio De Munari is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of proteasome inhibitors. With a total of seven patents to his name, his work has the potential to impact the treatment of various diseases, including cancer.
Latest Patents
One of Sergio De Munari's latest patents focuses on proteasome inhibitors and methods of using the same. This invention provides boronic acid compounds, boronic esters, and compositions that can modulate apoptosis by inhibiting proteasome activity. The compounds and compositions can be utilized in methods for inducing apoptosis and treating diseases associated directly or indirectly with proteasome activity. This innovative approach highlights the potential for new therapeutic strategies in combating serious health conditions.
Career Highlights
Throughout his career, Sergio De Munari has worked with prominent companies in the pharmaceutical industry. Notable among these are Cephalon, Inc. and Sigma-Tau Industrie Farmaceutiche Riunite S.p.a. His experience in these organizations has contributed to his expertise and success as an inventor.
Collaborations
Sergio has collaborated with several professionals in his field, including Alberto Bernareggi and Ernesto Menta. These partnerships have likely enriched his work and expanded the impact of his inventions.
Conclusion
Sergio De Munari's innovative work in the development of proteasome inhibitors showcases his significant contributions to the pharmaceutical industry. His patents and collaborations reflect a commitment to advancing medical science and improving treatment options for patients.